Helium One Global (AIM:HE1) has made its first helium sale from the Galactica project in Colorado, with CEO Lorna Blaisse describing the milestone as transformational. Multiple wells are tied in, with 24/7 operations and a farm-out process underway at its project in Tanzania. Galliford Try (LSE:GFRD) expects full-year profit at the top end of market forecasts, with average monthly cash up 21%. The order book has grown to £4.3 billion, with 90% of next year's revenue already secured. Bango (AIM:BGO) says annual recurring revenue jumped 31% to $20.4 million in the first half, with cash EBITDA already beating the whole of last year. Full-year adjusted EBITDA is expected to rise 34%. Iofina (AIM:IOF) has posted record first-half iodine production of just under 394 metric tons, up 29% year on year. Its first Permian Basin plant is due online in Q3 and is a key part of the next phase of growth. London BTC Company (LSE:BTC) has staked its fourth Nevada gold project, Black Star, with surface samples returning up to 16 grams per tonne gold. Lab results are pending across all four projects. Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk. Read Proactive's Editorial Policy here: https://www.proactiveinvestors.co.uk/pages/editorialPolicy

Iofina PLC (AIM:IOF, OTC:IOFNF) president and CEO Dr Tom Becker joined Proactive to discuss record first-half iodine production and the path towards 2,000 metric tons of annual output. Iofina produced just under 394 metric tons in the first half, up 29% year-on-year, driven by plant expansion and continued operational execution. The near-term focus is IO#12, the company's first Permian Basin plant, expected to open late in Q3 with annual capacity of 170-220 metric tons — larger than its Oklahoma operations and a key part of the next growth phase. Increased water availability at IO#11 is expected to add further production. On demand, Becker highlighted continued growth in human healthcare, particularly X-ray contrast media, alongside strong animal health applications, with Iofina adding customers as output expands. Looking further ahead, the company is evaluating partnerships to develop larger plants and accelerate build timelines. Having completed roughly one plant per year, Becker said the pace is set to increase. "We're going to accelerate that growth plan here moving forward," he said. Visit Proactive’s YouTube channel for more interviews and market updates. Give the video a like, subscribe to the channel and enable notifications for future content. #Iofina #IO12 #Iodine #IodineProduction #IodineMarket #PermianBasin #ProducedWater #IO11 #ProductionGrowth #HealthcareDemand #XRayContrastMedia #InvestorUpdate #OilAndGas #BusinessGrowth

Iofina PLC (AIM:IOF, OTC:IOFNF) told investors it produced a record 393.3 metric tonnes of crystalline iodine in the first half of 2026, beating its upgraded guidance as output jumped 29% year on year. Production across the company’s eight Oklahoma plants increased from 305.5 tonnes a year...

The UK market has recently faced challenges, with the FTSE 100 index experiencing a downturn due to weak trade data from China, highlighting global economic uncertainties. Despite these broader market pressures, investors often look to penny stocks as a potential avenue for growth. Though the term "penny stocks" might seem outdated, these typically smaller or newer companies can offer unique opportunities for those seeking investments with strong financial health and long-term potential.

Iofina PLC (AIM:IOF, OTC:IOFNF) has reported a fresh set of record financial results, underpinned by higher iodine prices and expanding production capacity. Chief executive Dr Tom Becker outlined the company’s progress and near-term growth plans in a recent interview with Proactive. Below...

Iofina PLC (AIM:IOF, OTC:IOFNF) CEO Thomas Becker joined Steve Darling from Proactive to discuss the company’s latest financial performance, highlighting a series of record-breaking results in its audited full-year report for the period ending December 2025. Becker outlined that the company delivered another standout year, reporting revenue of $66.5 million—an increase of 22% year-over-year—marking its eighth consecutive year of sustained growth. He attributed much of this momentum to strong operational performance across its core iodine business, with crystalline iodine sales surging by 42%, while iodine derivatives sales posted a solid 5% increase. This top-line growth translated into significant profitability gains. Gross profit rose 36% to $18.0 million, supported by improved efficiencies and favourable pricing. Adjusted EBITDA saw an even sharper rise of 56%, reflecting strong operational leverage, while operating profit climbed 74%. Profit before tax reached $8.4 million, representing a 75% increase compared to the previous year, underscoring the company’s ability to convert revenue growth into bottom-line performance. Looking ahead, Becker emphasized Iofina’s strategic focus on scaling its production footprint. A key component of this plan is the company’s expansion into the Permian Basin, where it is developing a larger-scale IOsorb® plant. This move represents the next phase in Iofina’s transformational growth strategy, shifting toward fewer but significantly larger facilities designed to enhance efficiencies and boost overall output. He noted that this transition to larger-scale plants is expected to materially increase production capacity while lowering unit costs, positioning the company for continued margin expansion and long-term growth. Momentum has carried into 2026, with the company reporting a strong start to the year. As a result, Iofina has raised the top end of its first-half 2026 production guidance and now expects output to reach approximately 385 metric tonnes. Becker added that the company has a clear near-term pathway to surpass 1,000 metric tonnes of annual production, with longer-term plans to exceed 2,000 metric tonnes through the continued rollout of larger-scale IOsorb® facilities. #proactiveinvestors #iofinaplc #aim #iof #iodine #permianbasin #crystallineiodine #ChemicalIndustry #FinancialResults #RevenueGrowth #EBITDA #ProfitGrowth #PermianBasin #IOsorb #IndustrialChemicals #ProductionGrowth #EnergyChemicals #MarketExpansion #OperationalEfficiency #BusinessGrowth